Extending Maintenance Flush Intervals for Implanted Ports at VA Northeast Ohio Healthcare System (VANEOHS)October 1, 2021Oncology
Novel and Alternative Strategies for Management of Panitumumab-Induced HypomagnesemiaOctober 1, 2021Oncology
A Single-Center Experience of Cardiac-related Adverse Events from Immune Checkpoint InhibitorsOctober 1, 2021CardiologyOncology
FDA approval for tisotumab vedotin in advanced cervical cancerSeptember 30, 2021OncologyWomen's HealthCancer
Study supports chemotherapy with immunotherapy for some never-smokers with lung cancerSeptember 28, 2021Lung CancerOncologyCancer
Duty to Assist: Assisting Veterans with Exposures to Hazardous MaterialsSeptember 27, 2021OncologyCancer
Evaluation of the Impact of the VHA National Precision Oncology Program (NPOP) on Prior Authorization Adjudication of Targeted Anti-Cancer AgentsSeptember 23, 2021Oncology
Most community-based oncologists skip biomarker testingSeptember 21, 2021Lung CancerOncologyGenitourinary CancerMelanoma
FDA approves first oral drug for NSCLC with EGFR Exon 20 insertionSeptember 20, 2021Lung CancerOncologyCancer
